NCT01947972

Brief Summary

Neonatal nutrition has to face a contradictory and conflicting nutritional regimen like a high percentage of amino acids from the first day of life in order to achieve normal neurodevelopment versus metabolic complications (insulin resistance, hyperglycemia, increased visceral fat) that this type feeding, in conjunction with complexity of prematurity, is likely to cause. Current study aims to investigate is whether individualized fortification of breast milk protein, based on the mother's milk protein content and targeting the recommended daily protein requirements, is associated with better nutrition, growth, biochemical and endocrine markers associated with the nutrition of preterm low birth weight neonates, compared to the standard fortification of human milk.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2013

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 10, 2013

Completed
13 days until next milestone

First Posted

Study publicly available on registry

September 23, 2013

Completed
8 days until next milestone

Study Start

First participant enrolled

October 1, 2013

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2016

Completed
Last Updated

July 13, 2016

Status Verified

July 1, 2016

Enrollment Period

2.8 years

First QC Date

September 10, 2013

Last Update Submit

July 12, 2016

Conditions

Keywords

preterm neonatetailored fortificationnutritionmaternal breast milk composition

Outcome Measures

Primary Outcomes (1)

  • Mean protein intake per kg of body weight between the groups

    participants will be followed until discharge and at 40 weeks post gestational age

Secondary Outcomes (4)

  • growth assessment differences between groups

    participants will be followed until discharge and at 40 weeks post gestational age

  • Differences in bioelectrical impedance between groups

    participants will be followed until discharge and at 40 weeks post gestational age

  • Mean daily dietary intake of mothers and correlation with macronutrients of their's breast milk

    from the moment of intervention, at least once in 10days, and until the end of intervention

  • Biochemical (lipidemic profile differences) between groups

    at 36weeks post conceptual age and follow-up at 40 weeks postconceptual age

Study Arms (1)

protein intake of 4g/kg/d

OTHER

Tailored protein fortification and nutritional status of preterm neonate. 4.5g protein per kg for preterms with body weight less than 1000g and 4g protein per kg for preterms with body weight more than 1000g, after human milk analysis. Intervention regards protein supplementation to fulfil the exact protein needs of preterms

Dietary Supplement: Tailored protein fortification

Interventions

4-4.5g of protein/kg/d

protein intake of 4g/kg/d

Eligibility Criteria

Age24 Hours - 5 Days
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Infants with gestational age ≤ 34weeks
  • very low birth weight (≤ 1500g)

You may not qualify if:

  • maternal health problems contradicting breastfeeding
  • genetic or chromosomal abnormalities
  • metabolic contraindications for increased amount of protein

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hippokration Hospital Thessaloniki

Thessaloniki, Greece

Location

MeSH Terms

Conditions

Metabolic Syndrome

Condition Hierarchy (Ancestors)

Insulin ResistanceHyperinsulinismGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic Diseases

Study Officials

  • Elisavet Diamanti, Dr

    AUTH

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dietitian - phD candidate

Study Record Dates

First Submitted

September 10, 2013

First Posted

September 23, 2013

Study Start

October 1, 2013

Primary Completion

July 1, 2016

Study Completion

July 1, 2016

Last Updated

July 13, 2016

Record last verified: 2016-07

Locations